Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anne Bruun Rovsing"'
Autor:
Ian Helstrup Nielsen, Anne Bruun Rovsing, Jacob Hørlück Janns, Emil Aagaard Thomsen, Albert Ruzo, Andreas Bøggild, Frederikke Nedergaard, Charlotte Thornild Møller, Thomas Boesen, Søren Egedal Degn, Jagesh V. Shah, Jacob Giehm Mikkelsen
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 4, Pp 102318- (2024)
To fully utilize the potential of CRISPR-Cas9-mediated genome editing, time-restricted and targeted delivery is crucial. By modulating the pseudotype of engineered lentivirus-derived nanoparticles (LVNPs), we demonstrate efficient cell-targeted deliv
Externí odkaz:
https://doaj.org/article/5b0da4b8e2504d17b7dca8efcfd345d5
Autor:
Emil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson, Hanne Due, Jinrong Huang, Yonglun Luo, Karen Dybkær, Jacob Giehm Mikkelsen
Publikováno v:
Molecular Oncology, Vol 14, Iss 9, Pp 1978-1997 (2020)
Diffuse large B‐cell lymphoma (DLBCL) is characterized by extensive genetic heterogeneity, and this results in unpredictable responses to the current treatment, R‐CHOP, which consists of a cancer drug combination supplemented with the humanized C
Externí odkaz:
https://doaj.org/article/db68e49e73e744989b9cfb52fe01b91f
Autor:
Anne Bruun Rovsing, Emil Aagaard Thomsen, Ian Nielsen, Thomas Wisbech Skov, Yonglun Luo, Karen Dybkær, Jacob Giehm Mikkelsen
The frontline therapy R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL) has remained unchanged for two decades despite numerous phase III clinical trials investigating new alternatives. Multiple large studies have uncovered genetic subty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8d3b8b702e902fe91a616b839246150
https://doi.org/10.1101/2023.01.19.524713
https://doi.org/10.1101/2023.01.19.524713
